Respiratory
Pneumothorax: spontaneous vs traumatic, management algorithm
— Primary spontaneous (PSP): no underlying lung disease; classic patient is a tall, thin, young male smoker 18–40 years old, often from subpleural apical bleb rupture
— Secondary spontaneous (SSP): underlying lung disease — COPD (most common), cystic fibrosis, TB, Pneumocystis pneumonia in HIV, lung cancer, LAM, Birt-Hogg-Dubé, Marfan, Ehlers-Danlos
— Traumatic: blunt (rib fracture lacerating pleura) or penetrating (stab, GSW)
— Iatrogenic: subclavian/IJ central line, transthoracic biopsy, thoracentesis, mechanical ventilation barotrauma, pacemaker placement
— Tension PTX: any of the above with one-way valve → progressive intrapleural pressure → mediastinal shift, decreased venous return, obstructive shock
— Catamenial: recurrent PTX in menstruating women due to thoracic endometriosis
— Sudden unilateral pleuritic chest pain + dyspnea, especially after coughing, weightlifting, scuba diving, or air travel
— Post-procedure hypoxia after central line placement or thoracentesis
— Trauma patient with chest wall injury and hypotension unresponsive to fluids
— Ventilated patient with sudden rise in peak airway pressures and drop in BP

— Onset typically at rest (not during exertion, contrary to intuition)
— Tall, thin male, 10–30 years old, smoker; family history in ~10%
— Symptoms may be mild and self-limiting; some patients delay presentation by days
— Older patient with known COPD, prior TB, cystic fibrosis, or HIV/AIDS with prior PCP
— Even small PTX causes severe dyspnea because of poor baseline reserve — do not be falsely reassured by small size
— Blunt: MVC, fall from height — look for rib fractures, flail chest, pulmonary contusion
— Penetrating: stab/GSW — assume hemopneumothorax until proven otherwise
— Delayed PTX can appear 24–48 hours post-trauma
— Smoking (RR ~20× in heavy smokers), cannabis use
— Barotrauma: scuba diving ascent, high-altitude flight, valsalva, vigorous cough
— Connective tissue disease: Marfan, Ehlers-Danlos, homocystinuria
— Menstrual cycle timing → catamenial PTX (within 72 h of menses, right-sided in 90%)
— Progressive dyspnea, tachycardia >120, hypotension, altered mental status
— Distended neck veins, tracheal deviation away from affected side (late finding)

— Tachypnea, accessory muscle use, asymmetric chest expansion (decreased on affected side)
— In trauma: chest wall ecchymoses, paradoxical motion (flail chest), penetrating wounds, subcutaneous emphysema ("Rice Krispies" crepitus)
— Decreased tactile fremitus over PTX (air conducts poorly)
— Tracheal deviation toward affected side in atelectasis but away in tension PTX
— Crepitus from subcutaneous air extending to neck/face
— Simple PTX: usually normotensive, mild tachycardia, SpO₂ may be normal or mildly reduced
— Tension PTX: hypotension, tachycardia >120, JVD, hypoxia, severe respiratory distress, ultimately PEA arrest from obstructive shock
— Pulsus paradoxus may be present
— Ventilated patient: sudden ↑ peak inspiratory pressure, ↓ tidal volumes, ↓ BP, ↓ SpO₂ — assume tension until proven otherwise
— Trauma: perform eFAST including bilateral pleural views; absent lung sliding is highly sensitive

— Visceral pleural line with absent lung markings peripherally
— Deep sulcus sign on supine film (lucent costophrenic angle) — easily missed
— Measure size: British Thoracic Society uses interpleural distance at hilum (>2 cm = large); ACCP uses apex-to-cupula distance (>3 cm = large)
— Look for: rib fractures, subcutaneous emphysema, mediastinal shift, hydropneumothorax (air-fluid level)
— Highly sensitive (>90%) and specific for PTX, superior to supine CXR
— Findings: absent lung sliding, absent comet-tail artifacts, presence of "lung point" (pathognomonic)
— M-mode: "barcode/stratosphere sign" replaces normal "seashore sign"
— Left PTX: decreased precordial R-wave amplitude, T-wave inversions, right-axis deviation, low voltage — can mimic anterior MI or PE

— Recurrent PSP → identify blebs/bullae, surgical planning
— Suspected secondary PTX → characterize underlying lung disease (emphysema, cystic lung disease, LAM, PCP cysts)
— Trauma → detect occult PTX, hemothorax volume, associated injuries (aortic, diaphragmatic)
— Suspected complication: persistent air leak, malpositioned chest tube, empyema, bronchopleural fistula
— Pre-VATS evaluation
— FLCN gene testing for Birt-Hogg-Dubé
— Connective tissue evaluation: Marfan (FBN1), vascular Ehlers-Danlos (COL3A1) — critical because surgical risk and recurrence are high
— Refer to genetics if family history or syndromic features

— Immediate needle decompression → tube thoracostomy (chest tube), do not wait for imaging
— Resuscitate, secure airway as needed
— Small (<2 cm BTS / <3 cm ACCP) and asymptomatic: observation 4–6 hours with supplemental O₂ (accelerates pleural air resorption ~4×), repeat CXR, discharge if stable with 24–48 h follow-up
— Large or symptomatic: needle aspiration (14–16G catheter, 2nd ICS MCL) OR small-bore chest tube (8–14 Fr pigtail)
— Recent BTS 2023 guidelines allow conservative outpatient management of selected stable PSP regardless of size (Hallifax NEJM 2020 trial: noninferior to intervention with fewer complications)
— Almost always admit — even small PTX
— Tube thoracostomy preferred over aspiration; higher failure rate with aspiration due to diseased lung
— Early thoracic surgery consult given high recurrence and mortality
— Any size with hemodynamic instability, hemothorax, or need for positive-pressure ventilation → chest tube (28–32 Fr if hemothorax, smaller if pure PTX)
— Occult PTX (CT only, not on CXR) in stable patient without PPV → observation often acceptable
— Penetrating chest trauma → chest tube before intubation if possible (PPV converts simple to tension)

— High-flow O₂ (10–15 L/min non-rebreather) for all PTX patients, even if SpO₂ normal
— Mechanism: nitrogen washout creates partial pressure gradient → pleural air resorbs ~4× faster (~1.25%/day → ~4–5%/day)
— Caution in COPD/SSP: use lowest FiO₂ achieving target SpO₂ 88–92% to avoid CO₂ retention
— Pleuritic pain limits inspiration → atelectasis, hypoventilation
— Acetaminophen + NSAIDs (ibuprofen, ketorolac) first-line
— Opioids (morphine, hydromorphone) for severe pain or post-procedure; use cautiously to avoid respiratory depression
— Intercostal nerve blocks or thoracic epidural for rib fracture-associated PTX
— Trauma: 24-hour prophylaxis with cefazolin reduces empyema/pneumonia (EAST guidelines, weak recommendation)
— Non-trauma elective tube: not routinely indicated
— Talc (most effective, gold standard for malignant effusion-related PTX)
— Doxycycline (preferred for benign recurrent PTX, especially younger patients to preserve lung for future surgery)
— Premedicate with analgesia and lidocaine — procedure is intensely painful
— Varenicline (most effective monotherapy), bupropion, nicotine replacement (patch + gum/lozenge combination)
— Begin during admission; arrange behavioral counseling
— GnRH agonists (leuprolide) or combined OCPs suppress endometrial implants
— Often combined with VATS pleurodesis
— Routine systemic anticoagulation cessation isn't required, but hold for procedures per usual periprocedural protocols
— Bronchodilators only if underlying COPD/asthma

— 2nd ICS midclavicular line (traditional) OR 4th–5th ICS anterior axillary line (updated ATLS — better penetration in obese/muscular adults)
— 14G angiocatheter, ≥5 cm length; listen for rush of air; convert to chest tube ASAP
— Triangle of safety: lateral border pectoralis major, anterior border latissimus dorsi, 5th ICS, base of axilla
— Small-bore pigtail (8–14 Fr) for simple PTX — equally effective as large-bore, less painful
— Large-bore (28–36 Fr) for hemothorax, empyema, bronchopleural fistula, ventilated patients
— Connect to underwater seal ± wall suction (–20 cmH₂O)
— Confirm position with CXR; verify air column movement with respiration
— First-line option for stable PSP in some guidelines (BTS); avoids tube
— Success rate ~60–70% for PSP, <40% for SSP
— Indications: 2nd ipsilateral PTX, 1st contralateral, bilateral, persistent air leak >5–7 days, failure to re-expand, hemopneumothorax, high-risk occupation, tension PTX, large bullae on CT
— Components: bullectomy/blebectomy + mechanical pleurodesis (pleural abrasion) ± chemical pleurodesis (talc/doxycycline) or pleurectomy
— Reduces recurrence from ~30% to <5%
— Criteria: no air leak × 24 h, lung fully re-expanded, drainage <100–200 mL/24 h
— Remove at end-expiration or during Valsalva; occlusive dressing; CXR 1–4 h post-removal

— PTX in elderly is almost always secondary (COPD, malignancy, interstitial lung disease)
— Higher mortality (10–15% in SSP vs <1% in PSP) due to limited pulmonary reserve
— Symptoms may be atypical: confusion, fatigue, falls rather than classic pleuritic pain
— Lower threshold for admission, chest tube, and ICU monitoring
— Pain control balanced against delirium risk from opioids; consider scheduled acetaminophen + low-dose opioids + regional anesthesia
— Procedural risks elevated: bleeding (anticoagulation, antiplatelets), poor wound healing, malnutrition
— Pleurodesis decision-making: weigh recurrence risk against surgical morbidity; many elderly patients undergo chemical pleurodesis via chest tube rather than VATS
— Code status discussion before invasive intervention is essential
— Increased bleeding risk from uremic platelet dysfunction → desmopressin (DDAVP) 0.3 mcg/kg IV before chest tube if uremic and bleeding concern
— Contrast-enhanced CT generally avoided; non-contrast CT chest is fine for PTX evaluation
— Drug dosing: adjust opioids (avoid morphine → active metabolites accumulate; prefer hydromorphone, fentanyl), enoxaparin (reduce or use UFH if CrCl <30), NSAIDs generally avoided in CKD
— Hemodialysis patients: PTX risk elevated post-IJ catheter placement; use ultrasound guidance
— Coagulopathy + thrombocytopenia → increased procedural bleeding; transfuse platelets to >50K and consider FFP/4-factor PCC if INR markedly elevated and active bleed
— Hepatic hydrothorax can coexist with PTX → hydropneumothorax; manage underlying portal hypertension
— Avoid acetaminophen doses >2 g/day in severe cirrhosis; NSAIDs contraindicated (variceal bleed, hepatorenal syndrome)
— Sedation/analgesia: reduce dosing; avoid benzodiazepines (precipitate encephalopathy)
— Reverse if possible before non-emergent chest tube: vitamin K + 4F-PCC for warfarin; idarucizumab for dabigatran; andexanet alfa for apixaban/rivaroxaban
— In emergencies (tension PTX), do not delay decompression for reversal

— Rare but high-stakes; physiologic changes (↑ tidal volume, ↑ chest wall compliance, elevated diaphragm) may delay diagnosis
— CXR is safe with abdominal shielding (<0.1 mGy fetal dose, well below 50 mGy threshold)
— CT chest acceptable if needed for diagnosis or trauma
— Management mirrors non-pregnant: O₂, aspiration or small-bore chest tube, surgical consult for recurrent
— Avoid: NSAIDs in 3rd trimester (premature ductus closure), tetracyclines (teratogenic — so doxycycline pleurodesis contraindicated; use talc)
— Delivery planning: in late pregnancy with active or recent PTX, avoid Valsalva → consider assisted second stage (forceps/vacuum) or elective C-section; epidural anesthesia preferred over general (avoids PPV)
— Catamenial PTX may flare or remit during pregnancy
— Neonatal PTX: common in RDS, meconium aspiration, mechanical ventilation; transillumination of chest can be diagnostic
— Adolescent PSP: identical to adult PSP — tall, thin males; same algorithm
— Consider underlying syndromes (cystic fibrosis, Marfan) — get sweat chloride if recurrent
— Chest tube sizing: smaller bore appropriate; pigtails common
— PTX = poor prognostic marker; affects lung transplant candidacy
— Avoid pleurodesis if transplant candidate (creates surgical adhesions complicating explant)
— Discuss with transplant center before intervention
— Suspect PCP with any PTX in immunocompromised patient — treat with TMP-SMX + prednisone if PaO₂ <70 or A-a gradient >35
— Chest tubes have high failure rate; persistent air leaks common
— Pilots (commercial and military), divers, astronauts: even single PSP often warrants definitive surgical pleurodesis before return to duty
— FAA requires documented resolution + often surgical fixation before reinstatement
— Diving carries lifelong restriction unless surgical pleurodesis with documented integrity

— PSP: ~30% within 1 year, ~50% lifetime without definitive surgery
— SSP: ~40–55% recurrence; each episode carries 1–17% mortality
— Risk factors: continued smoking, tall stature, persistent blebs on CT, female sex (in some studies)
— Bleeding from torn pleural adhesions or intercostal vessels
— Massive: >1500 mL initial output or >200 mL/hr × 4 h → emergent thoracotomy
— >5–7 days of continuous air leak through chest tube
— Management: VATS, blood patch pleurodesis, endobronchial valves
— Occurs after rapid re-expansion of chronically collapsed lung (>72 h collapse, large PTX, rapid drainage)
— Unilateral pulmonary edema on the side of the PTX within minutes to hours of drainage
— Prevention: avoid suction initially; use water seal; drain gradually
— Treatment: supportive, supplemental O₂, diuretics, occasionally ventilatory support
— Malposition (intraparenchymal, subcutaneous, subdiaphragmatic — liver/spleen laceration)
— Infection: cellulitis, empyema (1–25% incidence)
— Pain, intercostal neuralgia
— Refractory air leak from tube perforating lung
— Vascular injury (intercostal artery, internal mammary)

— Tension PTX (post-decompression observation)
— Bilateral PTX
— Hemodynamic instability, vasopressor requirement
— Mechanical ventilation requirement
— Massive hemopneumothorax
— Severe underlying lung disease (SSP with PaO₂ <60 or PaCO₂ rising)
— Re-expansion pulmonary edema
— Polytrauma with PTX
— Stable SSP requiring chest tube
— Large PSP requiring chest tube
— Significant comorbidities (advanced age, CKD, CHF)
— Stable PSP with chest tube/pigtail, no respiratory compromise
— Trauma PTX without other indications for higher level
— Small asymptomatic PSP for observation
— Selected stable PSP with Heimlich valve and reliable follow-up (newer pathway)
— Thoracic surgery:
— 2nd ipsilateral PTX, 1st contralateral, bilateral simultaneous
— Persistent air leak >5–7 days
— Failure of lung re-expansion >72 h
— Hemopneumothorax requiring operative management
— High-risk occupation (pilot, diver) after first PTX
— Suspected underlying surgical pathology (bullae, malignancy)
— Pulmonology: SSP, recurrent PTX, suspected underlying lung disease, cystic lung disease workup
— Interventional radiology: image-guided pigtail placement in difficult anatomy or loculated collections
— Trauma surgery: penetrating chest trauma, polytrauma
— Cardiothoracic: suspected aortic, tracheobronchial, or esophageal injury
— Genetics: familial PTX, suspected Birt-Hogg-Dubé, Marfan, vEDS
— Gynecology: catamenial PTX
— OB: pregnant patient with PTX
— Infectious disease: HIV/PCP, TB-related PTX
— Bronchoscopic intervention required (endobronchial valves for persistent air leak)
— Cystic fibrosis with PTX (transplant program coordination)
— Pediatric or pregnancy-specific expertise needed

— Sudden pleuritic chest pain + dyspnea + hypoxia — mimics PTX
— Distinguishing: PE typically has clear lungs on CXR, normal-to-increased breath sounds; D-dimer elevated; CT-PA diagnostic
— Wells score or PERC rule for risk stratification
— Pleuritic pain + dyspnea but with fever, productive cough, leukocytosis, infiltrate on CXR
— Breath sounds present (often with crackles), not absent
— Dyspnea + decreased breath sounds, but dull to percussion (vs hyperresonant in PTX)
— Decreased tactile fremitus in both
— Bilateral wheezing, prolonged expiratory phase
— Always rule out PTX in COPD patient with sudden worsening dyspnea — PTX can be missed and is catastrophic
— Hypoxia, crackles, infiltrate; often coexists with PTX
— Often a complication, not a primary diagnosis; persistent air leak post-PTX or post-pneumonectomy
— Penetrating or blunt trauma; massive PTX with persistent large air leak despite functioning chest tube; subcutaneous emphysema disproportionate to PTX size
— Bronchoscopy diagnostic; surgical repair
— Substernal pain, Hamman's crunch, subcutaneous emphysema; CXR shows mediastinal air outlining structures
— Causes: spontaneous (cough, vomiting, valsalva), Boerhaave esophageal rupture, asthma, marijuana/cocaine inhalation, barotrauma
— Can mimic PTX on CXR — bulla has concave inner border following lung contour; PTX has convex visceral pleural line
— CT distinguishes; chest tube into bulla = disaster (creates iatrogenic bronchopleural fistula)
— Bowel in chest on CXR; mimics hydropneumothorax; CT or upper GI study diagnostic

— Substernal pressure, radiating to arm/jaw, diaphoresis, nausea
— ECG, troponin distinguish; left PTX can mimic anterior MI on ECG (precordial T-wave inversions, axis shift)
— Always get ECG in chest pain, but don't anchor — CXR/ultrasound rules out PTX
— Sudden tearing chest/back pain, pulse deficits, widened mediastinum on CXR
— CT angiography diagnostic; can coexist with traumatic PTX
— Pleuritic chest pain relieved by leaning forward (pericarditis); muffled heart sounds, JVD, pulsus paradoxus, hypotension (tamponade)
— Tamponade and tension PTX both cause obstructive shock — bedside ultrasound distinguishes
— Beck's triad: hypotension, JVD, muffled heart sounds
— Severe retrosternal pain after forceful vomiting; left pleural effusion ± pneumomediastinum; Hamman's crunch
— Gastrografin esophagram or CT with oral contrast; surgical emergency
— Reproducible with palpation; benign; diagnosis of exclusion in young patients
— Often coexists with traumatic PTX; flail chest if ≥3 contiguous ribs in ≥2 places
— Dermatomal pain preceding vesicular rash by 2–4 days; can mimic pleuritic chest pain
— Tachypnea, chest tightness, tingling, perioral numbness; normal exam and CXR
— Diagnosis of exclusion in young patients
— Substernal burning, related to meals, responds to antacids
— Dyspnea, syncope, RV strain on ECG/echo
— Kussmaul respirations, fruity breath, high glucose, anion gap; can be confused with respiratory distress

— Recurrence drops ~4× in those who quit
— Initiate before discharge: varenicline (start 1 wk before quit date, titrate; most effective monotherapy), bupropion SR, or nicotine replacement therapy (combination patch + short-acting form)
— Behavioral counseling + quitline referral (1-800-QUIT-NOW)
— Document smoking status as quality measure
— No air travel until radiographic resolution + 1–2 weeks (most guidelines say 1 week after full resolution; BTS suggests 7 days; FAA varies)
— No scuba diving — ever unless definitive surgical pleurodesis with documented integrity (lifetime restriction otherwise)
— Avoid heavy lifting, valsalva, strenuous exercise for 2–4 weeks
— Avoid wind instruments and high-altitude exposure (>8000 ft) for several weeks
— Analgesia: scheduled acetaminophen + as-needed NSAID + short-course opioid only if needed (Step 3 emphasizes opioid stewardship — limit to <3 days where possible)
— Continue inhalers if underlying COPD/asthma
— Smoking cessation pharmacotherapy
— Bowel regimen if on opioids
— VTE prophylaxis if reduced mobility
— Discuss for all SSP, recurrent PSP, high-risk occupations
— Reduces recurrence from 30% to <5%
— Outpatient CXR at 2 weeks and 6 weeks post-discharge
— Pulmonology referral for SSP, recurrent PTX, suspected underlying lung disease
— Genetics referral if syndromic features or familial pattern
— Address modifiable factors: smoking, marijuana, cocaine, body weight (low BMI is risk factor)
— Influenza annually, pneumococcal (PCV20 or PCV15+PPSV23) per age/comorbidity, COVID boosters
— Especially important in SSP/COPD patients

— Continuous pulse oximetry, vital signs q4h
— Chest tube parameters: air leak (column oscillation, bubbling in water seal chamber), drainage volume/character, tidaling (respiratory variation in fluid column)
— Daily CXR initially, then as clinically indicated
— Pain assessment and analgesia titration
— Incentive spirometry q1h while awake to prevent atelectasis
— No air leak for ≥24 hours
— Lung fully re-expanded on CXR
— Drainage <100–200 mL/24 h (varies by institution)
— Patient off positive-pressure ventilation
— Remove at end-expiration or during Valsalva; CXR 1–4 hours after removal
— Observe 4–6 hours, repeat CXR
— Discharge if stable; counsel on return precautions
— 2 weeks post-discharge: clinic visit + CXR — assess symptoms, confirm radiographic resolution
— 6 weeks: repeat CXR if persistent abnormalities at 2 weeks, or sooner if symptomatic
— Pulmonology/thoracic surgery follow-up for definitive management discussion if SSP or recurrent
— Sudden chest pain, worsening dyspnea, fever, redness/drainage at tube site → ED
— Recurrence presents identically to initial episode
— Indicated for SSP patients with COPD or significant underlying lung disease
— Improves exercise tolerance, QOL, reduces exacerbations
— Smoking cessation (revisit at every visit)
— Drug avoidance: marijuana, cocaine, inhalants
— Recreational restrictions: diving, skydiving, high-altitude activities
— Sexual activity and Valsalva activities: generally avoid 2–4 weeks
— Return to work: sedentary work 1–2 weeks; heavy labor 4–6 weeks
— Future pregnancy planning if applicable
— Smoking cessation counseling documented
— Appropriate vaccines administered
— Follow-up arranged before discharge

— Chest tube/VATS: discuss risks (bleeding, infection, organ injury, recurrence, persistent air leak, chronic pain), benefits, alternatives
— Emergent tension PTX: implied consent applies — decompression is life-saving and cannot wait for formal consent; document clinical reasoning
— Pleurodesis: ensure patient understands it eliminates future potential for lung transplantation in some cases (CF patients especially)
— Hypoxia and pain can impair capacity — reassess after stabilization
— Adolescent assent for PSP procedures; parental consent required
— Penetrating chest trauma (gunshot, stabbing) → notify law enforcement per state law
— Suspected intimate partner violence or child abuse if injury pattern doesn't fit history
— When PTX results from central line, biopsy, or thoracentesis: transparent disclosure to patient and family is ethically and legally required
— Document procedure indication, technique, complication, response
— Quality improvement reporting; not all iatrogenic complications are negligence
— Use ultrasound guidance for central line placement (reduces PTX risk by ~50%)
— Time-out and site verification before procedures — wrong-side chest tube is a never event
— Standardized chest tube insertion checklists reduce complications
— Safe handoff: communicate chest tube parameters, suction settings, last CXR at every shift change
— Discharging a PTX patient without confirmed follow-up CXR is a high-liability error
— Ensure clear written instructions on return precautions, activity restrictions, and travel avoidance
— Medication reconciliation — especially anticoagulants if held periprocedurally
— Confirm patient has primary care follow-up arranged before discharge
— Document that diving and flying restrictions were discussed (especially pilots — FAA certification implications)
— Failure to counsel about diving risk is a known malpractice exposure
— Avoid routine repeated CXRs once stable; choose pigtail over large-bore tube when appropriate (reduced pain, faster discharge, lower cost)
— Frail elderly with recurrent SSP from end-stage COPD: discuss goals of care, palliative options (Heimlich valve for comfort, avoid repeated invasive procedures)

— Bilateral PTX
— Recurrent (2nd ipsilateral or 1st contralateral)
— Air leak persistent >5–7 days
— Ventilation requirement / non-re-expansion
— Occupational risk (pilot, diver)
— 2nd episode

— "22-year-old tall thin male smoker develops sudden right-sided pleuritic chest pain and dyspnea while watching TV. Exam: decreased breath sounds and hyperresonance on right. Vitals stable. CXR shows 3 cm rim of air at apex."
— Answer: Needle aspiration or small-bore chest tube + O₂ + admit/observe; counsel smoking cessation, no air travel, no diving
— "Trauma patient with multiple rib fractures becomes hypotensive (BP 80/40), tachycardic, with JVD and absent breath sounds on left. SpO₂ 82%."
— Answer: Immediate needle decompression, then chest tube — NOT chest X-ray first
— "68-year-old with severe COPD presents with sudden dyspnea. SpO₂ 84% on 4L. CXR shows 1.5 cm PTX on right."
— Answer: Admit, chest tube (even though small), thoracic surgery consult; do not aspirate or observe — SSP is different
— "Following subclavian central line, patient develops dyspnea. CXR shows moderate PTX."
— Answer: Small-bore chest tube if symptomatic/large; observation + O₂ if small and asymptomatic; ensure ultrasound guidance documented for future
— "30-year-old woman with 3rd right-sided PTX, each occurring within 2 days of menses."
— Answer: VATS pleurodesis + hormonal suppression (GnRH agonist or OCP); evaluate for thoracic endometriosis
— "Mechanically ventilated ARDS patient develops sudden hypotension, rising peak airway pressures, decreased breath sounds on left."
— Answer: Needle decompression immediately, then chest tube
— "First PTX 6 months ago, now presents with 2nd ipsilateral PTX."
— Answer: Chest tube + thoracic surgery for VATS pleurodesis
— "Commercial pilot after first PSP asks when he can fly."
— Answer: After resolution and consideration of definitive surgical pleurodesis for return to flight duty; lifelong diving ban without surgery
— "HIV patient with CD4 80, dyspnea, bilateral infiltrates, and left PTX."
— Answer: TMP-SMX + steroids for PCP + chest tube
— "After chest tube placement for large chronic PTX, patient develops ipsilateral pulmonary edema."
— Answer: Supportive care, supplemental O₂, diuretics; lesson learned: drain to water seal slowly, no suction initially

Pneumothorax management hinges on three questions — Is the patient stable? Is the lung disease primary or secondary? And is the PTX small or large? — with tension physiology being a clinical diagnosis requiring immediate needle decompression and tube thoracostomy without waiting for imaging.

